National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

Past Highlights
   
 
Results: 1 -6 of 6         results per page
View Search Criteria | Help With Results
           

1.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II, Phase I


Treatment


Active


18 and over


Pharmaceutical / Industry


GRN163L CP04-151
NCT00124189


2.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II, Phase I


Treatment


Active


18 and over


Pharmaceutical / Industry


GRN163L CP14A010
NCT00732056


3.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase I


Treatment


Active


18 and over


Pharmaceutical / Industry


GRN163L CP05-101
NCT00310895


4.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase I


Treatment


Active


18 and over


Pharmaceutical / Industry


GRN163L CP14A005
NCT00510445


5.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase I


Treatment


Active


18 and over


Pharmaceutical / Industry


GRN163L CP14A004
NCT00594126


6.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase I


Treatment


Active


18 and over


Pharmaceutical / Industry


GRN163L CP14A011
NCT00718601

   
   

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov